Skip to main content

Table 5 Mid-term other outcomes in studies included in review on mid-term and long-term effects of tourniquet use

From: The mid-term and long-term effects of tourniquet use in total knee arthroplasty: systematic review

Study Details

Outcome measured

Outcome measurement tool

Mid-term outcomes

Time point (month)

Score

p value

Time point (month)

Score

p value

Group Aa

Group Bb

Group Cc

Group Aa

Group Bb

Ejaz, et al (2014) [12]

QOL

KOOS-QOL

6

81.377

80.972

 

n.s.

12

83.81

84.21

n.s.

Huang, et al (2017) [19]

Pt. Sat.

Sat.

3

        

Ext. Sat.

19

34

32

n.s.

V. Sat.

16

12

15

SW Sat.

9

4

2

N. sat. nor dissat.

5

0

1

SW Dissat.

1

0

0

V. Dissat.

0

0

0

Ext. Sat.

6

22

34

33

n.s.

V. Sat.

20

13

14

SW Sat.

4

3

2

N. sat. nor dissat.

3

0

1

SW Dissat.

1

0

0

V. Dissat.

0

0

0

Jawhar, et al (2019) [20]

Pt. Dep.

HADS Depression

6

3 ± 3.07

3 ± 4

 

n.s.

    

Pt. Sat.

Mancuso Score

6

34 ± 8.36

36 ± 16.11

 

n.s.

Pt. SF hth.

EQ VAS

6

74 ± 17.40

75 ± 17.47

 

n.s.

HR QOL

EQ 5D Index

6

0.91 ± 0.08

0.91 ± 0.08

 

n.s.

Pt. Anxiety

HADS-Anxiety

6

3 ± 2.91

4 ± 3.93

 

n.s.

Liu, et al (2014) [28]

Limb Inf.

Knee Circum. (cm)

6

44.16 ± 0.66

40.47 ± 0.60

 

n.s.

12

41.27 ± 2.31

42.62 ± 5.79

sig.

Limb Inf.

Thigh Circum. (cm)

6

47.90 ± 0.79

41.23 ± 1.03

 

n.s.

12

48.22 ± 10.96

46.79 ± 10.72

n.s.

Touzopoulos, et al (2019) [48]

Pt. Sat.

KSS-Sat.

     

36

35.57 ± 5.48

34.65 ± 5.82

n.s.

Pt. Expec.

KSS- Expec.

36

9.04 ± 1.64

9.08 ± 1.46

n.s.

Alexandersson, et al (2018) [6]

Limb Inf.

Knee Circum. (cm)

3

44.6

44.7

 

n.s.

    

Molt, et al (2014) [35]

Limb Al.

HKA index (°)

3

179 ± 4

179 ± 3

 

n.s.

    

Dennis, et al (2015) [10]

Limb Inf.

Thigh Girth (cm)

3

46.05 ± 5.57

45.97 ± 6.14

 

n.s.

    

Limb Inf.

Calf Girth (cm)

3

36.31 ± 3.68

36.16 ± 3.87

 

n.s.

Limb Inf.

Knee Girth (cm)

3

43.9 ± 4.42

43.53 ± 4.29

 

n.s.

Rathod, et al (2014) [40]

Limb Inf

KSSF

3

42.6 ± 5.1

43.1 ± 3.9

 

n.s.

12

41.7 ± 3.9

42.9 ± 6.9

n.s.

Gen. hth.

PCS

3

40.72 ± 7.75

42.79 ± 8.31

 

n.s.

12

49.58 ± 7.34

49.55 ± 8.28

n.s.

Gen. hth.

MCS

3

47.96 ± 11.53

48.8 ± 11.11

 

n.s.

12

54.45 ± 7.51

53.68 ± 9.36

n.s.

Limb Inf.

MPC (cm)

3

106 ± 15

109 ± 12

 

n.s.

12

116 ± 43

119 ± 42

n.s.

Chaudhry, et al (2020) [9]

Pt. QOL

SF-12 ± SD

6

39.32 ± 1.471

39.35 ± 2.102

 

n.s.

    
  1. QOL Quality of Life, Pt. Patient, Sat. Satisfaction, Ext. Extreme, V Very, SW Somewhat, N. sat. not dissat. Neither satisfied nor dissatisfied, Dep. Depression, SF hth. Self Rated Health, HR Health Related, Circum Circumference, HADS Hospital Anxiety and Depression Score, EQ EuroQol, 5D 5 Dimensions, Gen. General, KSSF Knee Society Score Functional, PCS Physical Component Score, MCS Mental Component Score, MPC Mid-patellar Circumference, HKA Index Hip Knee Ankle Index, SF-12 12-Item Short Form Health Survey, n.s. non-significant, Inf. Inflammation, Al. Alignment, sig. significant
  2. atourniquet use/ long duration tourniquet use
  3. btourniquet use/ short duration use
  4. ctourniquet use with tranexamic acid